Filing Details
- Accession Number:
- 0001209191-17-048480
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-10 19:14:54
- Reporting Period:
- 2017-08-08
- Filing Date:
- 2017-08-10
- Accepted Time:
- 2017-08-10 19:14:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621334 | Pat Cotroneo | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Vp, Finance And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-08 | 10,000 | $3.50 | 173,366 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-08-08 | 85,000 | $14.58 | 258,366 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-08 | 10,989 | $49.70 | 247,377 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-08 | 78,304 | $50.69 | 169,073 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-08 | 5,707 | $51.28 | 163,366 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-08-08 | 10,000 | $0.00 | 10,000 | $3.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-08-08 | 85,000 | $0.00 | 85,000 | $14.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,000 | 2021-06-07 | No | 4 | M | Direct | |
| 17,254 | 2024-03-19 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $49.20 to $50.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $50.20 to $51.175. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $51.20 to $51.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
